Optimizing platelet inhibition in peripheral artery disease: A comparison of mono-antiplatelet therapy and dual-antiplatelet therapy using thromboelastography
Vascular · 2025
DOI: 10.1177/17085381241237005 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Vascular, 2025. Verfasst von Ivy Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, MA, USA. Hauptthemen laut MEDLINE: Aspirin, Blood Platelets, Clopidogrel, Dual Anti-Platelet Therapy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: NIH R21, Haemonetics Corp.
Abstract (Originalsprache)
Background
Antiplatelet therapy is used to prevent thrombosis in patients with peripheral artery disease (PAD) following revascularization. However, the current standard of care for these patients remains at the physician’s discretion, varying from mono-antiplatelet therapy (MAPT) to dual-antiplatelet therapy (DAPT). Viscoelastic assays such as Thromboelastography with Platelet Mapping (TEG-PM) provide insight into individual coagulation profiles and measure real-time platelet function. This prospective, observational study looks at the differences in platelet function for patients on MAPT versus DAPT using TEG-PM.
Methods
Patients with PAD undergoing revascularization were prospectively evaluated between December 2020 and June 2023. TEG-PM analysis compared platelet function for patients prescribed MAPT (aspirin or clopidogrel) at the initial encounter and DAPT (aspirin and clopidogrel) at the next visit. Platelet function measured in percent inhibition was evaluated at these visits, and within-group t-tests were performed.
Results
Of the 195 patients enrolled, 486 samples were analyzed by TEG-PM. Sixty-four patients met the study criteria. At the initial visit, 52 patients had been prescribed aspirin, and 12 patients had been prescribed clopidogrel. For patients initially prescribed aspirin MAPT, an increase of 96.8%in the mean ADP platelet inhibition was exhibited when transitioning to DAPT [22.0% vs. 43.3%, p < .01], as well as an increase of 34.6%in the mean AA platelet inhibition when transitioning to DAPT [60.9% vs. 82.0%, p < .01]. For patients prescribed initial clopidogrel MAPT, an increase of 100% in AA platelet inhibition was exhibited on DAPT compared to the MAPT state [42.3% vs. 84.6%, p < .01].
Conclusions
Patients on DAPT showed a significant increase in platelet inhibition when compared to initial aspirin MAPT. A significant difference in AA %platelet inhibition was shown for patients on DAPT when compared to initial clopidogrel MAPT. The results show that patients may benefit from DAPT post-revascularization. Personalizing antiplatelet therapy with objective viscoelastic testing to confirm adequate treatment may be the next step in optimizing patient outcomes to reduce thrombosis in PAD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, MA, USA.
- Tufts University School of Medicine, Boston, MA, USA.
ORCID-Profile: Ivy Lee, Monica Majumdar
Förderung
- NIH R21
- Haemonetics Corp
Zitieren
APA
Lee, I., Suarez, S., Hall, R., Majumdar, M., Bellomo, T., Jessula, S., Nuzzolo, K., Jefferson, D. M., Zacharias, N., & Dua, A. (2025). Optimizing platelet inhibition in peripheral artery disease: A comparison of mono-antiplatelet therapy and dual-antiplatelet therapy using thromboelastography. Vascular. https://doi.org/10.1177/17085381241237005
Vancouver
Lee I, Suarez S, Hall R, Majumdar M, Bellomo T, Jessula S, et al. Optimizing platelet inhibition in peripheral artery disease: A comparison of mono-antiplatelet therapy and dual-antiplatelet therapy using thromboelastography. Vascular. 2025. doi:10.1177/17085381241237005
BibTeX
@article{Lee2025,
author = {Lee, Ivy and Suarez, Sasha and Hall, Ryan and Majumdar, Monica and Bellomo, Tiffany and Jessula, Samuel and Nuzzolo, Kathryn and Jefferson, Douglas M and Zacharias, Nikolaos and Dua, Anahita},
title = {Optimizing platelet inhibition in peripheral artery disease: A comparison of mono-antiplatelet therapy and dual-antiplatelet therapy using thromboelastography},
journal = {Vascular},
year = {2025},
doi = {10.1177/17085381241237005}
}
EUVIMED